EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment

Javier Chao-Pellicer, Iñigo Arberas-Jiménez, Frieder Fuchs iD, Ines Sifaoui, José E Piñero iD, Jacob Lorenzo-Morales, Patrick Scheid

Antibiotics · 03.08.2023 · 12 (8) · 1280

DOI: 10.3390/antibiotics12081280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 03.08.2023. Verfasst von Javier Chao-Pellicer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203 …. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación Biomédica en Red, Agencia Canaria de Investigación, Innovación y Sociedad de la Información, Consorcio Centro de Investigación Biomédica (CIBER) de Enfermedades Infecciosas (CIBERINFEC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among the pathogenic free-living amoebae (FLA), Naegleria fowleri is the etiological agent of a fatal disease known as primary amoebic meningoencephalitis (PAM). Once infection begins, the lesions generated in the central nervous system (CNS) result in the onset of symptoms leading to death in a short period of time. Currently, there is no standardized treatment against the infection, which, due to the high virulence of the parasite, results in a high case fatality rate (>97%). Therefore, it is essential to search for new therapeutic sources that can generate a rapid elimination of the parasite. In recent years, there have already been several successful examples of drug repurposing, such as Nitroxoline, for which, in addition to its known bioactive properties, anti-Balamuthia activity has recently been described. Following this approach, the anti-Naegleria activity of Nitroxoline was tested. Nitroxoline displayed low micromolar activity against two different strains of N. fowleri trophozoites (IC50 values of 1.63 ± 0.37 µM and 1.17 ± 0.21 µM) and against cyst stages (IC50 of 1.26 ± 0.42 μM). The potent anti-parasitic activity compared to the toxicity produced (selectivity index of 3.78 and 5.25, respectively) in murine macrophages and human cell lines (reported in previous studies), together with the induction of programmed cell death (PCD)-related events in N. fowleri make Nitroxoline a great candidate for an alternative PAM treatment.

Schlagwörter

Stichwörter der Autor:innen

8-hydroxy-quinolineNaegleria fowleriNitroxolinedrug repurposingprimary amoebic meningoencephalitisprogrammed cell death

Autor:innen und Institutionen

  • Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203 San Cristóbal de La Laguna, Spain.
  • Departamento de Obstetricia y Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de La Laguna, 38203 San Cristóbal de La Laguna, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28220 Madrid, Spain.
  • Department of Microbiology and Hospital Hygiene, Bundeswehr Central Hospital Koblenz, 56072 Koblenz, Germany.
  • Institute for Medical Microbiology, Immunology and Hygiene, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50935 Cologne, Germany.
  • Parasitology Lab., Central Military Hospital Koblenz, 56072 Koblenz, Germany.

ORCID-Profile: Frieder Fuchs, José E Piñero

Förderung

  • Centro de Investigación Biomédica en Red
  • Agencia Canaria de Investigación, Innovación y Sociedad de la Información
  • Consorcio Centro de Investigación Biomédica (CIBER) de Enfermedades Infecciosas (CIBERINFEC)
  • Instituto de Salud Carlos III, 28006 Madrid, Spain

Zitieren

APA

Chao-Pellicer, J., Arberas-Jiménez, I., Fuchs, F., Sifaoui, I., Piñero, J. E., Lorenzo-Morales, J., & Scheid, P. (2023). Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment. Antibiotics, 12(8), 1280. https://doi.org/10.3390/antibiotics12081280

Vancouver

Chao-Pellicer J, Arberas-Jiménez I, Fuchs F, Sifaoui I, Piñero JE, Lorenzo-Morales J, et al. Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment. Antibiotics. 2023;12(8):1280. doi:10.3390/antibiotics12081280

BibTeX
@article{ChaoPellicer2023,
  author = {Chao-Pellicer, Javier and Arberas-Jiménez, Iñigo and Fuchs, Frieder and Sifaoui, Ines and Piñero, José E and Lorenzo-Morales, Jacob and Scheid, Patrick},
  title = {Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment},
  journal = {Antibiotics},
  year = {2023},
  volume = {12},
  number = {8},
  pages = {1280},
  doi = {10.3390/antibiotics12081280}
}
Kostenlos starten →